Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,211
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Letters

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants

Xiao-Feng Lia Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Na-Na Zhanga Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China;b School of Medicine, Tsinghua University, Beijing, ChinaView further author information
,
Yu-Hua Lic Department of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing, ChinaView further author information
,
Shou-Chun Caoc Department of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing, ChinaView further author information
,
Yi-Fei Zhanga Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
&
Cheng-Feng Qina Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China;b School of Medicine, Tsinghua University, Beijing, ChinaCorrespondence[email protected]
View further author information
Article: 2094142 | Received 09 May 2022, Accepted 21 Jun 2022, Published online: 11 Jul 2022

References

  • Zhang N-N, Li X-F, Deng Y-Q, Zhao H, Huang Y-J, Yang G, Huang W-J, Gao P, Zhou C, and Zhang R-R, et al. A thermostable mRNA vaccine against COVID-19. Cell. 2020;182(5):1–2. doi:10.1016/j.cell.2020.07.024.
  • Chen GL, Li X-F, Dai X-H, Li N, Cheng M-L, Huang Z, Shen J, Ge Y-H, Shen Z-W, Deng Y-Q, et al. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Microbe. 2022;3(3):e193–2. doi:10.1016/S2666-5247(21)00280-9.
  • Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19(7):409–424. doi:10.1038/s41579-021-00573-0.
  • Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021;593(7857):130–135. doi:10.1038/s41586-021-03398-2.
  • Kuzmina A, Khalaila Y, Voloshin O, Keren-Naus A, Boehm-Cohen L, Raviv Y, Shemer-Avni Y, Rosenberg E, Taube R. SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera. Cell Host Microbe. 2021;29(4):522–528 e522. doi:10.1016/j.chom.2021.03.008.
  • Shen X, Tang H, McDanal C, Wagh K, Fischer W, Theiler J, Yoon H, Li D, Haynes BF, Sanders KO, et al. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines. Cell Host Microbe. 2021;29(4):529–539 e523. doi:10.1016/j.chom.2021.03.002.
  • Liu Y, Liu J, Xia H, Zhang X, Fontes-Garfias CR, Swanson KA, Cai H, Sarkar R, Chen W, Cutler M, et al. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med. 2021;384(15):1466–1468. doi:10.1056/NEJMc2102017.
  • Pegu A, O’-Connell SE, Schmidt SD, O’-Dell S, Talana CA, Lai L, Albert J, Anderson E, Bennett H, Corbett KS, et al. Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants. Science. 2021;373(6561):1372–1377. doi:10.1126/science.abj4176.
  • Liu J, et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron. Nature. 2022. doi:10.1038/s41586-022-04465-y.
  • Keeton R, Tincho MB, Ngomti A, Baguma R, Benede N, Suzuki A, Khan K, Cele S, Bernstein M, Karim F, et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature. 2022;603(7901):488–492. doi:10.1038/s41586-022-04460-3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.